ARUP Laboratories

Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are essential for the diagnosis of VEXAS syndrome and concurrent hematologic neoplasms.

ARUP medical directors will present key hematopathology research at the 66th ASH Annual Meeting, including developments in systemic mastocytosis treatment and testing for myeloid malignancy mutations.

ARUP Laboratories will host the Park City Anatomic Pathology Update from February 9–13, 2025. The event will feature topics on gastrointestinal (GI), pancreatic, and hepatobiliary pathology.